Vectura Group launches JV with Hong Kong private equity firm

UK-based pharmaceutical company Vectura Group has gained access to the lucrative Chinese market by launching a joint venture with two partners including a Hong Kong-based private equity firm. The Tianjin Kinnovata Pharmaceutical Company joint venture has been established in partnership with Chinese pharmaceutical company Tianjin KingYork Group and with private equity firm Zendex Bio Strategy, …